Release Date: November 14, 2024

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

• Lifeway Foods Inc (NASDAQ:LWAY) reported a 12.7% increase in net sales for Q3 2024, marking the 20th consecutive quarter of growth.

• The company achieved its second-largest quarterly net sales ever, driven by strong demand for its flagship Lifeway Drinkable Kefir.

• Gross profit margin improved to 25.7% for Q3 2024, with expectations for further margin expansion due to manufacturing efficiencies.

• Lifeway Foods Inc (NASDAQ:LWAY) is expanding its product offerings with new lactose-free and reduced sugar options, appealing to health-conscious consumers.

• The company is strategically expanding its distribution network, including new markets in South Africa and Dubai, enhancing its global presence.

Negative Points

• Selling, general, and administrative expenses increased to $7.5 million for Q3 2024, indicating higher operational costs.

• Capital spending rose by $2.2 million to $5.4 million, reflecting increased investments to meet demand, which could impact cash flow.

• The macroeconomic environment remains challenging, with consumers facing higher prices and interest rates, potentially affecting spending.

• Despite strong sales growth, the company's net income was $3 million, which may not fully reflect the top-line performance.

• Lifeway Foods Inc (NASDAQ:LWAY) continues to de-prioritize private label manufacturing, which could limit diversification in revenue streams.

Q & A Highlights

• Warning! GuruFocus has detected 2 Warning Sign with LWAY.

Q: Can you elaborate on the factors driving the double-digit growth in net sales for the third quarter of 2024? A: Julie Smolyansky, CEO, explained that the growth was primarily volume-driven, particularly from the flagship Lifeway Drinkable Kefir. This marks the 20th consecutive quarter of net sales growth, highlighting strong consumer demand for Lifeway's products. The strategic sales and marketing investments have been successful in driving this demand and trial usage.

Q: How is Lifeway Foods managing its expenses, particularly in terms of selling, general, and administrative expenses? A: Julie Smolyansky, CEO, noted that selling, general, and administrative expenses were $7.5 million for the quarter. The company continues to invest in strategic sales and marketing to drive product trial and accelerate velocities, which is reflected in the consistent top-line strength.

Q: What are the company's plans for capital spending, and how does it align with Lifeway's growth strategy? A: Julie Smolyansky, CEO, stated that capital spending increased to $5.4 million during the nine-month period ended September 30, 2024. The spending focuses on supporting growth, cost reductions, and facility improvements, ensuring the company has the capacity to meet demand and support continued business growth.